Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRaw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tg Therapeutics (TGTX) Prepaid Assets (2016 - 2025)

Tg Therapeutics has reported Prepaid Assets over the past 10 years, most recently at $57.6 million for Q4 2025.

  • Quarterly results put Prepaid Assets at $57.6 million for Q4 2025, up 266.38% from a year ago — trailing twelve months through Dec 2025 was $57.6 million (up 266.38% YoY), and the annual figure for FY2025 was $57.6 million, up 266.38%.
  • Prepaid Assets for Q4 2025 was $57.6 million at Tg Therapeutics, up from $55.8 million in the prior quarter.
  • Over the last five years, Prepaid Assets for TGTX hit a ceiling of $57.6 million in Q4 2025 and a floor of $2.5 million in Q3 2021.
  • Median Prepaid Assets over the past 5 years was $7.6 million (2024), compared with a mean of $14.4 million.
  • Biggest five-year swings in Prepaid Assets: tumbled 54.51% in 2021 and later surged 308.97% in 2023.
  • Tg Therapeutics' Prepaid Assets stood at $2.9 million in 2021, then skyrocketed by 46.91% to $4.2 million in 2022, then soared by 124.66% to $9.5 million in 2023, then skyrocketed by 65.1% to $15.7 million in 2024, then skyrocketed by 266.38% to $57.6 million in 2025.
  • The last three reported values for Prepaid Assets were $57.6 million (Q4 2025), $55.8 million (Q3 2025), and $25.4 million (Q2 2025) per Business Quant data.